In a groundbreaking move, the Allan government in Victoria has announced that general practitioners (GPs) will soon be able to diagnose and treat Attention Deficit Hyperactivity Disorder (ADHD) for ...
ADHD is a neurological condition that impacts millions of Australians, with estimates suggesting that between 6 and 10 percent of children and adolescents, and 2 to 6 percent of adults are affected.
As China released a high-tech medical device to help some 23 million children suffering from attention deficit hyperactivity disorder (ADHD), scientists and medical experts have called for the ...
The young woman smiles widely as she prepares to get on the horse for her weekly ride. She laughs as the horse takes its ...
General practitioners in Victoria are set to receive professional training to diagnose and treat attention deficit ...
Getting the care you need for ADHD can be hard enough.Trying to urgently replace a lost, expired or depleted prescription can be even harder.That's ...
Total net revenue of $15.2 million Adjusted EBITDA1 of $(0.8) million, which includes EXXUA launch investments $30.0 million cash balance at December 31, 2025 Company launched EXXUA™ (gepirone) ...
A new model of care is needed to reduce waiting lists for children with attention deficit hyperactivity disorder (ADHD) and other neurodivergent conditions who are often “pushed to the back of the ...
Australian Associated Press on MSN

'Too long': green light for more GPs to tackle ADHD

States are continuing to shake up the way a prevalent developmental disorder is treated by allowing more health professionals ...
Specialist GPs will soon be able to diagnose and treat ADHD in both children and adults in Victoria, cutting wait times and costs for care and ...
Advertised as the most well-known telemedicine brand, we had a psychologist try Teladoc’s online therapy service for one ...
Total net revenue of $15.2 millionAdjusted EBITDA1 of $(0.8) million, which includes EXXUA launch investments$30.0 million cash balance at December 31, 2025Company launched EXXUA (gepirone) extended-r ...